These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22159013)

  • 1. The vitreous glycoprotein opticin inhibits preretinal neovascularization.
    Le Goff MM; Lu H; Ugarte M; Henry S; Takanosu M; Mayne R; Bishop PN
    Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):228-34. PubMed ID: 22159013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin.
    Del Amo EM; Griffiths JR; Klaska IP; Hoke J; White A; Aarons L; Cooper GJS; Bainbridge JWB; Bishop PN; Unwin RD
    Mol Pharm; 2020 Jul; 17(7):2390-2397. PubMed ID: 32437164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization.
    Klaska IP; White A; Villacampa P; Hoke J; Abelleira-Hervas L; Maswood RN; Ali RR; Bunce C; Unwin RD; Cooper GJS; Bishop PN; Bainbridge JW
    Exp Eye Res; 2022 Feb; 215():108908. PubMed ID: 34954204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localisation of opticin in human proliferative retinal disease.
    Pattwell DM; Sheridan CM; Le Goff M; Bishop PN; Hiscott P
    Exp Eye Res; 2010 Mar; 90(3):461-4. PubMed ID: 20036236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalisation of opticin in the human eye.
    Ramesh S; Bonshek RE; Bishop PN
    Br J Ophthalmol; 2004 May; 88(5):697-702. PubMed ID: 15090426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of opticin binding to collagen fibrils identifies a single binding site in the gap region and a high specificity towards thin heterotypic fibrils containing collagens II, and XI or V/XI.
    Hansen U; Holmes DF; Bruckner P; Bishop PN
    PLoS One; 2020; 15(8):e0234672. PubMed ID: 32764753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
    Barnett JM; McCollum GW; Fowler JA; Duan JJ; Kay JD; Liu RQ; Bingaman DP; Penn JS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):907-15. PubMed ID: 17251494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opticin Ameliorates Hypoxia-Induced Retinal Angiogenesis by Suppression of Integrin α2-I Domain-Collagen Complex Formation and RhoA/ROCK1 Signaling.
    Liu X; Xing Y; Liu X; Zeng L; Ma J
    Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):13. PubMed ID: 35006271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene.
    Takanosu M; Boyd TC; Le Goff M; Henry SP; Zhang Y; Bishop PN; Mayne R
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2202-10. PubMed ID: 11527931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesiveness.
    Le Goff MM; Sutton MJ; Slevin M; Latif A; Humphries MJ; Bishop PN
    J Biol Chem; 2012 Aug; 287(33):28027-36. PubMed ID: 22669977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opticin binds retinal growth hormone in the embryonic vitreous.
    Sanders EJ; Walter MA; Parker E; Arámburo C; Harvey S
    Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5404-9. PubMed ID: 14638744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opticin production is reduced by hypoxia and VEGF in human retinal pigment epithelium via MMP-2 activation.
    Ma J; Zhu TP; Moe MC; Ye P; Yao K
    Cytokine; 2012 Jul; 59(1):100-7. PubMed ID: 22534113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opticin binds to heparan and chondroitin sulfate proteoglycans.
    Hindson VJ; Gallagher JT; Halfter W; Bishop PN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4417-23. PubMed ID: 16303928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
    Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
    Gu X; Samuel S; El-Shabrawey M; Caldwell RB; Bartoli M; Marcus DM; Brooks SE
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):496-502. PubMed ID: 11818396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix.
    Reardon AJ; Le Goff M; Briggs MD; McLeod D; Sheehan JK; Thornton DJ; Bishop PN
    J Biol Chem; 2000 Jan; 275(3):2123-9. PubMed ID: 10636917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice.
    Pan H; Nguyen NQ; Yoshida H; Bentzien F; Shaw LC; Rentier-Delrue F; Martial JA; Weiner R; Struman I; Grant MB
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2413-9. PubMed ID: 15223825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.